Medicinal properties of <i>Terminalia arjuna (Roxb.) Wight & Arn</i>.: A review.

J Tradit Complement Med · 2017 · PMC5198828 · PMID 28053890

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

arjuna extracts in reducing metaphase aberrations due to aflatoxin B 1 (AFB1) is quite significant, the reduction varying from 23.49%, 42.47%, and 59.65% down to 12.32%, 28.00%, and 36.88% respectively at the highest dose T. arjuna for the three different durations viz., 24, 48 and 72 h.

also in 5,682 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.